Ruben Tommasi - Net Worth and Insider Trading
Ruben Tommasi Net Worth
The estimated net worth of Ruben Tommasi is at least $149,500 dollars as of 2025-05-01. Ruben Tommasi is the Chief Scientific Officer of Entasis Therapeutics Holdings Inc and owns about 68,265 shares of Entasis Therapeutics Holdings Inc (ETTX) stock worth over $149,500. Details can be seen in Ruben Tommasi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ruben Tommasi has not made any transactions after 2021-10-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ruben Tommasi
Ruben Tommasi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ruben Tommasi owns 1 companies in total, including Entasis Therapeutics Holdings Inc (ETTX) .
Click here to see the complete history of Ruben Tommasi’s form 4 insider trades.
Insider Ownership Summary of Ruben Tommasi
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc | 2021-10-19 | Chief Scientific Officer |
Ruben Tommasi Latest Holdings Summary
Ruben Tommasi currently owns a total of 1 stock. Ruben Tommasi owns 68,265 shares of Entasis Therapeutics Holdings Inc (ETTX) as of October 19, 2021, with a value of $149,500.
Latest Holdings of Ruben Tommasi
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc | 2021-10-19 | 68,265 | 2.19 | 149,500 |
Holding Weightings of Ruben Tommasi
Ruben Tommasi Form 4 Trading Tracker
According to the SEC Form 4 filings, Ruben Tommasi has made a total of 1 transactions in Entasis Therapeutics Holdings Inc (ETTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Entasis Therapeutics Holdings Inc is the sale of 3,759 shares on October 19, 2021, which brought Ruben Tommasi around $11,991.
Insider Trading History of Ruben Tommasi
- 1
Ruben Tommasi Trading Performance
Ruben Tommasi Ownership Network
Ownership Network List of Ruben Tommasi
Ownership Network Relation of Ruben Tommasi
Ruben Tommasi Owned Company Details
What does Entasis Therapeutics Holdings Inc do?
Who are the key executives at Entasis Therapeutics Holdings Inc?
Ruben Tommasi is the Chief Scientific Officer of Entasis Therapeutics Holdings Inc. Other key executives at Entasis Therapeutics Holdings Inc include 10 percent owner Theravance Inc , VP & Principal Fin & Acct Off Kristie Ann Wagner , and Chief Medical Officer David Altarac .
Entasis Therapeutics Holdings Inc (ETTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Entasis Therapeutics Holdings Inc (ETTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entasis Therapeutics Holdings Inc (ETTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Entasis Therapeutics Holdings Inc (ETTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entasis Therapeutics Holdings Inc Insider Transactions
Ruben Tommasi Mailing Address
Above is the net worth, insider trading, and ownership report for Ruben Tommasi. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ruben Tommasi's mailing address is: C/o Entasis Therapeutics Holdings Inc. 35 Gatehouse Drive Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
